News Releases

New State-By-State Scorecard Reveals Wide Gaps in Access to Obesity Treatments

FOR IMMEDIATE RELEASE CONTACT: ASMBSNews@compartnersny.com Study Compared Data Across 44 Metrics to Find Best and Worst States for Access to...

Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide...

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will present the results from the 16-week double-blind...

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial...

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced positive topline results from LUCIDITY, a...

Bariatric Surgery More Effective Than GLP-1 Drugs at Preventing Heart Attacks, Stroke...

CONTACT: ASMBSNews@compartnersny.com Bariatric Surgery More Effective Than GLP-1 Drugs at Preventing Heart Attacks, Stroke and Death in Older Adults SAN...

Bariatric Surgery Significantly More Effective Than GLP-1 Drugs for Weight Loss and...

CONTACT: ASMBSNews@compartnersny.com Analysis of 430,000+ Patients Finds Surgery Outperforms Across Every Key Measure SAN ANTONIO – May 6, 2026 –...

Bariatric Surgery Procedures Fall Below 200,000, First Time Since 2020, New Research...

CONTACT: ASMBSNews@compartnersny.com Bariatric Surgery Procedures Fall Below 200,000, First Time Since 2020, New Research Finds SAN ANTONIO – May 5,...

New Study Finds Metabolic and Bariatric Surgery After GLP-1 Treatment Significantly Boosts...

CONTACT: ASMBSNews@compartnersny.com Prior GLP-1 Use Does Not Compromise Surgical Effectiveness SAN ANTONIO – May 5, 2026 – People who begin...

Study Finds Bariatric Surgery Less Costly Than GLP-1 Drugs Over Time

CONTACT: ASMBSNews@compartnersny.com Real-World Analysis Reveals True Costs of Treatment after Two Years for Patients with Obesity and Type 2 Diabetes...

Bariatric Surgery Slashes Risk of Kidney Failure, Heart Attack and Death, New Data...

CONTACT: ASMBSNews@compartnersny.com Five-Year Real-World Outcomes Show Over 50% Lower Risk of Kidney Failure, Major Cardiovascular Events, Nearly 75% Lower Mortality...

As GLP-1 Use Skyrockets and Bariatric Surgery Slows, Most Obesity Goes Untreated

CONTACT: ASMBSNews@compartnersny.com Real-World Analysis Shows More than 90% of Patients Receive No Treatment SAN ANTONIO – May 5, 2026 –...